Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Total Liabilities (2016 - 2023)

Item 9 Labs' Total Liabilities history spans 13 years, with the latest figure at $59.4 million for Q2 2023.

  • For Q2 2023, Total Liabilities rose 41.29% year-over-year to $59.4 million; the TTM value through Jun 2023 reached $59.4 million, up 41.29%, while the annual FY2022 figure was $48.8 million, 58.99% up from the prior year.
  • Total Liabilities reached $59.4 million in Q2 2023 per INLB's latest filing, up from $56.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $59.4 million in Q2 2023 to a low of -$14.8 million in Q1 2019.
  • Average Total Liabilities over 5 years is $25.6 million, with a median of $15.0 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: soared 282.79% in 2019, then rose 26.11% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $9.1 million in 2019, then soared by 40.86% to $12.8 million in 2020, then surged by 154.7% to $32.6 million in 2021, then skyrocketed by 66.81% to $54.3 million in 2022, then grew by 9.31% to $59.4 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Total Liabilities are $59.4 million (Q2 2023), $56.4 million (Q1 2023), and $54.3 million (Q4 2022).